Franz Zehentmayr - Department of Radiation Oncology and radART-Institute for research and development on Advanced Radiation Technologies, Paracelsus Medical University

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 113 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Elvis Ruznic, Marisa Klebermass,Barbara Zellinger, Brigitte Langer,Brane Grambozov, Ayurzana Purevdorj,Josef Karner, Georg Gruber,Markus Stana,Danijela Minasch, Karoline Kirchhammer,Claudia Steffal,Heidi Stranzl,Raphaela Moosbrugger,Petra Feurstein,Karin Dieckmann,Franz Zehentmayr, ALLSTAR Group

Journal of clinical medicineno. 3 (2025)

Cited0Views0WOSBibtex

Immediate Start of Durvalumab after Chemoradiotherapy in Unresectable Non-Small Cell Lung Cancer UICC Stage III: Early Results from the TORG1937/DATE Study

Brane Grambozov,Markus Stana,Franz Zehentmayr

Journal of thoracic diseaseno. 1 (2025): 1-4

Cited0Views0WOSBibtex

Durvalumab Prolongs Overall Survival, Whereas Radiation Dose Escalation > 66 Gy Might Improve Long-Term Local Control in Unresectable NSCLC Stage III: Updated Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Franz Zehentmayr, Petra Feurstein,Elvis Ruznic, Brigitte Langer,Brane Grambozov, Marisa Klebermass, Alexandra Hochreiter, Ayurzana Purevdorj, Georg Gruber,Danijela Minasch, Barbara Breitfelder, Claudia Steffal, Karoline Kirchhammer,Heidi Stranzl, Falk Röder,Karin Dieckmann, ALLSTAR Group

Cancersno. 9 (2025)

Cited0Views0WOSBibtex

Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM Approaches

Sara Vockner,Matthias Mattke, Ivan M. Messner,Christoph Gaisberger,Franz Zehentmayr, Klarissa Ellmauer,Elvis Ruznic,Gerd Fastner,Josef Karner,Roland Reitsamer,Falk Roeder,Markus Stana

CANCERSno. 3 (2025)

Cited0Views0WOSBibtex

157P Durvalumab Impacts Progression-Free Survival but Not Local Control in Patients with Inoperable NSCLC Stage III: Real-world Data from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

F. Zehentmayr, P. Feurstein,E. Ruznic, B. Langer,B. Grambozov, M. Klebermass,H. Huepfel, J. Feichtinger,D. Minasch, M. Heilmann, B. Breitfelder,C. Steffal, G. Gastinger-Grass, K. Kirchhammer,M. Kazil,H. Stranzl,K. Dieckmann

ESMO Open (2024): 102912

Cited0Views0Bibtex

P Durvalumab Impacts Progression-Free Survival While High-Dose Radiation > 66 Gy Improves Local Control Without Excess Toxicity in Unresectable NSCLC Stage III: Real-world Data from the A Ustrian Radio-Oncologica L L Ung Cancer St Udy a Ssociation R Egistry (ALLSTAR)

Franz Zehentmayr,Petra Feurstein,Elvis Ruznic, Brigitte Langer,Brane Grambozov, Marisa Klebermass, Herbert Huepfel,Johann Feichtinger,Danijela Minasch,Martin Heilmann, Barbara Breitfelder,Claudia Steffal,Gisela Gastinger-Grass, Karoline Kirchhammer, Margit Kazil,Heidi Stranzl,Karin Dieckmann

RADIOTHERAPY AND ONCOLOGY (2024)

Cited0Views0Bibtex

Toxicity and Cosmetic Outcome after Intraoperative Radiotherapy with Electrons (IOERT) to the Partial Breast During Breast Conserving Surgery of Breast Cancer Patients in Early Stages: First Results of a Prospective Single-Center Registry Trial

G. Fastner,R. Reitsamer,C. Gaisberger,M. Stana,C. Fussl, M. Mattke,B. Grambozov,F. Zehentmayr,A. Sir, N. Annon-Eberharter, F. Roeder

EUROPEAN JOURNAL OF CANCER (2024): 59-59

Cited0Views0Bibtex

Durvalumab Impacts Progression-Free Survival While High-Dose Radiation >66 Gy Improves Local Control Without Excess Toxicity in Unresectable NSCLC Stage III: Real-world Data from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Franz Zehentmayr,Petra Feurstein,Elvis Ruznic, Brigitte Langer,Brane Grambozov, Marisa Klebermass, Herbert Hüpfel,Johann Feichtinger,Danijela Minasch,Martin Heilmann, Barbara Breitfelder,Claudia Steffal,Gisela Gastinger-Grass, Karoline Kirchhammer, Margit Kazil,Heidi Stranzl,Karin Dieckmann

Radiotherapy and Oncology（2024）

Cited0Views0WOSBibtex

377: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate in NSCLC III

Elvis Ruznic,Markus Stana,Brane Grambozov,Josef Karner,Isabella Gollner,Christoph Gaisberger,Barbara Zellinger,Raphaela Moosbrugger,Michael Studnicka,Gerd Fastner,Felix Sedlmayer,Franz Zehentmayr

RADIOTHERAPY AND ONCOLOGY (2024): S1603-S1604

Cited0Views0Bibtex

PO-1450 Hsa-miR-3651 Could Serve As a Novel Predictor for In-Breast Recurrence Via FRMD3

E. Ruznic,B. Zellinger, U. Bodenhofer, I.A. Engländer,C. Kronberger,B. Grambozov,M. Stana, J. Karner,G. Fastner, K. Sotlar,F. Sedlmayer,F. Zehentmayr

Radiotherapy and Oncology (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn